Trump drug price plan could nix investment, warns Roche / Photo: SEBASTIEN BOZON - AFP
-
Gay badminton star Gilmour urges progress on LGBTQ rights in Asia
-
Chinese ship sets off for Europe through Arctic, halving travel time
-
Pallister takes down Ledecky in Pan Pacs 800m freestyle
-
Bangladesh on verge of historic win in Australia as Mehidy takes five
-
Douglass breaks 50m free world record again to claim Pan Pacs gold
-
Messi sees penalty saved as Nashville routs Inter Miami in MLS
-
As Opel turns to Chinese partners, its hometown frets about the future
-
Heat is on as German winegrowers struggle to protect vines
-
Mehidy takes three as Bangladesh close on historic win in Australia
-
Hope fades for finding survivors of Colombia quake as rescued woman dies
-
Hope fades for finding surivivors of Colombia quake as rescued woman dies
-
Japan aims for the moons of Mars
-
Hurricane Lala dumps heavy rain on Hawaii
-
'People could get hurt': Conservationists decry AI wildlife visuals
-
Jaded voters, same old choices: Brazil kicks off election campaign
-
'Another chance to live': Flores residents recall quake panic
-
'Everyone lives in fear': Yemenis worry about return to all-out war
-
Rivers among nine inducted into Basketball Hall of Fame
-
Cardinals' Baez bashes record three homers in MLB debut
-
No.1 Scheffler leads by two at PGA St. Jude playoff event
-
Djokovic feels the heat in Cincinnati opening defeat
-
Rennie confident Jordan, Roigard will be fit to face Springboks
-
Hunt bags third Euro gold, Diaz shines in triple jump
-
PSG sign Belgian winger Godts from Ajax
-
Depleted Djokovic falls in Cincinnati Masters opener
-
Nillessen claims shock European 1,500m gold
-
Lala, now a hurricane, dumps heavy rain on Hawaii
-
Taylor scores two tries in winning debut as New Zealand captain
-
American Kate Douglass reclaims 50m freestyle world record
-
England defender Spence leaves Spurs for Inter Milan
-
Kit confusion disrupts Newcastle friendly against Leverkusen
-
Moore double leads Spurs to 3-0 friendly win over Hoffenheim
-
Marchand wins first Euros gold as Liebmann breaks 1500m free world record
-
Man Utd beaten by former boss Amorim's AC Milan in friendly finale
-
Zambia's vote marred by intimidation, counting pause: observers
-
Villagers evacuate as Belgium battles record wildfire
-
Marchand wins 200m butterfly for first Euros gold
-
Despite booming economy, young Moroccans still dream of Europe
-
Fernandez booed by Chelsea fans in friendly win over Sociedad
-
South Korea president proposes talks with North to formally end Korean War
-
Fans line Welsh streets as Bonnie Tyler body's returns for funeral
-
Residents evacuate as Belgium wildfire scorches 1,600 hectares
-
Tropical Storm Lala lashes Hawaii with heavy rain
-
easyJet strike sees 100 French flights cancelled
-
Lebanon reports 11 dead in strikes that Israel says targeted Hezbollah
-
Monica Bellucci and Florin Serban win at Locarno Film Festival
-
Crystal Palace sign Israel winger Khalaili
-
India's Padikkal hits unbeaten century in first Sri Lanka Test
-
Rescuers search for survivors as Indonesian quake death toll rises to 47
-
Liechtenstein places gender equality on its throne
Trump drug price plan could nix investment, warns Roche
President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche cancel major investments in the United States, it said Wednesday.
Trump signed an executive order Monday aimed at bringing down the notoriously high prescription drug prices paid by US consumers, news that rattled pharmaceutical companies.
Swiss newspaper NZZ reported Trump's move could lead Roche to reassess plans it announced just last month to invest $50 billion in the United States over five years.
Roche, the world leader in cancer treatments, said in a statement it did not expect Trump's new drugs policy to hurt its business in 2025.
"However, should the proposed EO (executive order) go into effect, Roche's ability to fund the significant investments previously announced in the US will be in question," it said.
Trump has been pushing foreign firms to invest more in the United States, saying the way to avoid his tariff assault on foreign-made goods is to produce them on US soil instead.
Prescription drugs were not targeted in Trump's "Liberation Day" tariff announcements.
Still, Roche appeared to take heed with its April investment announcement, which came just after fellow Swiss rival Novartis said it would increase investment in the United States by $23 billion over five years.
The United States is a key market for Roche, accounting for more than half its pharmaceutical division's revenues.
Roche's US subsidiary Genentech announced a $700-million project Monday to build a new plant in North Carolina, which it says would employ 400 people.
L.Mason--AMWN
